These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26718154)

  • 21. KHA-CARI Autosomal Dominant Kidney Disease Guideline: Management of Chronic Pain.
    Savige J; Tunnicliffe DJ; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):607-611.e3. PubMed ID: 26718166
    [No Abstract]   [Full Text] [Related]  

  • 22. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Pharmacological Management.
    Mallett A; Lee VW; Mai J; Lopez-Vargas P; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):582-589.e17. PubMed ID: 26718162
    [No Abstract]   [Full Text] [Related]  

  • 23. Autosomal dominant polycystic kidney disease: time for a change?
    Chapman AB
    J Am Soc Nephrol; 2007 May; 18(5):1399-407. PubMed ID: 17429048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Making an earlier diagnosis of ADPKD: implications for the treatment of hypertension.
    Perrone R; Miskulin DC
    Nephrol News Issues; 2006 Jun; 20(7):32, 35-6. PubMed ID: 16764142
    [No Abstract]   [Full Text] [Related]  

  • 25. Autosomal dominant policystic kidney disease, more than a renal disease.
    Torra R
    Minerva Endocrinol; 2014 Jun; 39(2):79-87. PubMed ID: 24736482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current situation of dominant autosomal renal polycystosis].
    Ibáñez R; Ocharán J
    An Med Interna; 1993 Jun; 10(6):299-302. PubMed ID: 8334210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Management of End-Stage Kidney Disease.
    Lee VW; Tunnicliffe DJ; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):595-602.e12. PubMed ID: 26718164
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical practice. Autosomal dominant polycystic kidney disease.
    Grantham JJ
    N Engl J Med; 2008 Oct; 359(14):1477-85. PubMed ID: 18832246
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical and laboratory markers of autosomal dominant polycystic kidney disease (ADPKD) progression: an overview.
    Corradi V; Gastaldon F; Virzì GM; Caprara C; Martino F; Ronco C
    Minerva Med; 2015 Feb; 106(1):53-64. PubMed ID: 25300895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cystic disease in women: clinical characteristics and medical management.
    Chapman AB
    Adv Ren Replace Ther; 2003 Jan; 10(1):24-30. PubMed ID: 12616460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical presentation and outcome of autosomal dominant polycystic kidney disease in Pakistan: a single center experience.
    Rabbani MA; Ali SS; Murtaza G; Ahmad B; Maria Q; Siddiqui BK; Shah SM; Ahmad A
    J Pak Med Assoc; 2008 Jun; 58(6):305-9. PubMed ID: 18988388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unilateral autosomal dominant polycystic kidney disease with contralateral renal agenesis: a case report.
    Jeong GH; Park BS; Jeong TK; Ma SK; Yeum CH; Kim SW; Kim NH; Choi KC
    J Korean Med Sci; 2003 Apr; 18(2):284-6. PubMed ID: 12692431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations.
    Spithoven EM; Meijer E; Boertien WE; Sinkeler SJ; Tent H; de Jong PE; Navis G; Gansevoort RT
    Am J Kidney Dis; 2013 Sep; 62(3):531-40. PubMed ID: 23714171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
    Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Bae KT; Baumgarten DA; Kenney PJ; King BF; Glockner JF; Wetzel LH; Brummer ME; O'Neill WC; Robbin ML; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
    Kidney Int; 2003 Sep; 64(3):1035-45. PubMed ID: 12911554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addressing "Second Hits" in the Pursuit of Greater Equity in Health Outcomes for Individuals with ADPKD.
    Mohottige D; McElroy LM; Boulware LE
    Clin J Am Soc Nephrol; 2022 Jul; 17(7):936-938. PubMed ID: 35725554
    [No Abstract]   [Full Text] [Related]  

  • 36. [New strategy for the treatment of autosomal dominant polycystic kidney disease].
    Horie S
    Nihon Jinzo Gakkai Shi; 2015; 57(1):254-61. PubMed ID: 25735085
    [No Abstract]   [Full Text] [Related]  

  • 37. Autosomal dominant polycystic kidney disease: emerging concepts of pathogenesis and new treatments.
    Braun WE
    Cleve Clin J Med; 2009 Feb; 76(2):97-104. PubMed ID: 19188475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Autosomal dominant polycystic kidney disease].
    Chauveau D; Ferrandiz I; Huart A
    Rev Prat; 2014 Nov; 64(9):1313-21. PubMed ID: 25638878
    [No Abstract]   [Full Text] [Related]  

  • 39. [Autosomal dominant polycystic kidney. Apropos of 2 cases. Review of the literature].
    Tsatsaris V; Rondeau E; Salat-Baroux J; Uzan S
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(5):529-32. PubMed ID: 9417467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease.
    Spithoven EM; Kramer A; Meijer E; Orskov B; Wanner C; Caskey F; Collart F; Finne P; Fogarty DG; Groothoff JW; Hoitsma A; Nogier MB; Postorino M; Ravani P; Zurriaga O; Jager KJ; Gansevoort RT; ; ; ; ;
    Kidney Int; 2014 Dec; 86(6):1244-52. PubMed ID: 24827775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.